U

UBCare Co Ltd
KOSDAQ:032620

Watchlist Manager
UBCare Co Ltd
KOSDAQ:032620
Watchlist
Price: 3 855 KRW 0.26% Market Closed
Market Cap: 201.2B KRW
Section:
 

Relative Value

The Relative Value of one UBCare Co Ltd stock under the Base Case scenario is 5 717.89 KRW. Compared to the current market price of 3 855 KRW, UBCare Co Ltd is Undervalued by 33%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
5 717.89 KRW
Undervaluation 33%
Relative Value
Price
U
Worst Case
Base Case
Best Case

Valuation Multiples

1
P/S
P/S
Price to Sales
1
vs History
85
vs Industry
65
Median 3Y
1.4
Median 5Y
1.9
Industry
2.3
More Details
5.1
P/E
P/E
Price to Earnings
5.1
vs History
63
vs Industry
6
Median 3Y
-66.2
Median 5Y
33.2
Industry
22.5
More Details
20.3
P/OCF
P/OCF
Price to OCF
20.3
vs History
96
vs Industry
1
Median 3Y
75.5
Median 5Y
43.5
Industry
14.5
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
1
Median 3Y
-73.5
Median 5Y
30.7
Industry
21.5
More Details
1.4
P/B
P/B
Price to Book Value
1.4
vs History
96
vs Industry
46
Median 3Y
2.2
Median 5Y
2.4
Industry
2.2
More Details
1
EV/S
EV/S
Enterprise Value to Sales
1
vs History
85
vs Industry
69
Median 3Y
1.3
Median 5Y
1.6
Industry
2.6
More Details
1.9
EV/GP
EV/GP
Enterprise Value to Gross Profit
1.9
vs History
85
vs Industry
72
Median 3Y
2.5
Median 5Y
3.1
Industry
5.2
More Details
13
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
13
vs History
92
vs Industry
19
Median 3Y
23.3
Median 5Y
21.9
Industry
11.9
More Details
28.1
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
28.1
vs History
73
vs Industry
4
Median 3Y
41.8
Median 5Y
31.6
Industry
16.9
More Details
19.1
EV/OCF
EV/OCF
Enterprise Value to OCF
19.1
vs History
96
vs Industry
1
Median 3Y
71.1
Median 5Y
36.9
Industry
14.7
More Details
37.3
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
37.3
vs History
49
vs Industry
2
Median 3Y
37.3
Median 5Y
37.3
Industry
18.7
More Details
1.1
EV/IC
EV/IC
Enterprise Value to IC
1.1
vs History
96
vs Industry
52
Median 3Y
1.7
Median 5Y
2.1
Industry
1.9
More Details

Multiples Across Competitors

Competitors Multiples
UBCare Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
KR
UBCare Co Ltd
KOSDAQ:032620
195.6B KRW 1 5.1 13 28.1
US
Veeva Systems Inc
NYSE:VEEV
37.7B USD 12.2 43.8 33.4 34.9
US
Cerner Corp
LSE:0R00
31.3B USD 5.4 53.1 21.9 43.2
AU
Pro Medicus Ltd
ASX:PME
24.3B AUD 110.4 211.3 146.1 146.1
JP
M3 Inc
TSE:2413
1.5T JPY 4.6 34.4 17.7 21.2
US
Doximity Inc
NYSE:DOCS
8.5B USD 13.6 33.5 29.4 30.8
SE
Sectra AB
STO:SECT B
52.5B SEK 24.6 89.7 -126.1 -126.1
US
Waystar Holding Corp
NASDAQ:WAY
5.3B USD 5.1 47.8 16 25.1
US
Inspire Medical Systems Inc
NYSE:INSP
4.1B USD 4.6 91.3 75.9 102
IN
Inventurus Knowledge Solutions Ltd
NSE:IKS
270.9B INR 10.1 55.7 34.7 40.5
US
Vocera Communications Inc
F:V00
2.4B EUR 12 -330.4 269.8 4 320.1
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
KR
U
UBCare Co Ltd
KOSDAQ:032620
Average EV/EBITDA: 65.8
13
N/A N/A
US
Veeva Systems Inc
NYSE:VEEV
33.4
39%
0.9
US
C
Cerner Corp
LSE:0R00
21.9
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
146.1
32%
4.6
JP
M3 Inc
TSE:2413
17.7
14%
1.3
US
Doximity Inc
NYSE:DOCS
29.4
23%
1.3
SE
Sectra AB
STO:SECT B
Negative Multiple: -126.1 N/A N/A
US
W
Waystar Holding Corp
NASDAQ:WAY
16
24%
0.7
US
Inspire Medical Systems Inc
NYSE:INSP
75.9
80%
0.9
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
34.7
24%
1.4
US
V
Vocera Communications Inc
F:V00
269.8
N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
KR
U
UBCare Co Ltd
KOSDAQ:032620
Average EV/EBIT: 479.2
28.1
N/A N/A
US
Veeva Systems Inc
NYSE:VEEV
34.9
39%
0.9
US
C
Cerner Corp
LSE:0R00
43.2
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
146.1
31%
4.7
JP
M3 Inc
TSE:2413
21.2
N/A N/A
US
Doximity Inc
NYSE:DOCS
30.8
25%
1.2
SE
Sectra AB
STO:SECT B
Negative Multiple: -126.1 N/A N/A
US
W
Waystar Holding Corp
NASDAQ:WAY
25.1
56%
0.4
US
Inspire Medical Systems Inc
NYSE:INSP
102
34%
3
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
40.5
27%
1.5
US
V
Vocera Communications Inc
F:V00
4 320.1
N/A N/A

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 302,200+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.